Endotoxins (lipopolysaccharides, LPS) are constituents of the outer me
mbrane of gram-negative bacteria. The application of purified LPS to e
xperimental animals leads to the development of many pathophysiologica
l activities which are also seen during infection with gram-negative m
icroorganisms. One important prerequisite for the development of endot
oxin shock is the interaction of LPS with macrophages, the activation
of which leads to the release of cytokines, in particular of TNFalpha
and IL-1, which mediate the toxic activity of LPS. The interaction of
LPS with target cells and the subsequent initiation of endotoxin shock
may be modified by plasma proteins that are capable of binding LPS. T
he most important LPS-binding proteins known so far are high density l
ipoprotein (HDL), low density lipoprotein (LDL), LPS-binding protein (
LBP) and specific LPS antibodies. Native LPS released from bacteria ma
y be associated partly with bacterial proteins (e.g. OmpA) which may a
lso modify its interaction with host targets. The sensitivity of the o
rganism to LPS is genetically determined, but may be altered under dif
ferent experimental conditions. Hypersensitivity to LPS may be achieve
d by treatment with live (infection) or killed microorganisms, growing
tumors, hepatotoxic agents or treatment with proteins to which the or
ganism has been immunologically primed. The state of hypersensitivity
is characterized by an increased ability of hypersensitive animals to
produce cytokines on LPS challenge, as well as by an increased suscept
ibility to the toxic activity of TNFalpha. Recently it could be shown
that interferon gamma (IFNgamma) is a central mediator in the developm
ent of the hypersensitivity to LPS induced by infection.